Given the speed of the sell-off, leaked news about Lecanemab did cross my mind as well. However, Eisai and Biogen haven't had the same sell off.
Ann: Annual Report, page-11
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.080(5.88%) |
Mkt cap ! $219.4M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.32 | $1.27 | $64.71K | 50.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3514 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 5 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.31 |
Change
-0.080 ( 6.43 %) |
||||
| Open | High | Low | Volume | ||
| $1.29 | $1.32 | $1.28 | 6234 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| CGS (ASX) Chart |